<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6832137\results\search\tropicalVirus\results.xml">
  <result pre="viruses, such as hepatitis C virus (HCV), dengue virus (DENV)," exact="Zika" post="virus (ZIKV), human immunodeficiency virus (HIV), and influenza virus"/>
  <result pre="of the Flaviviridae family of viruses that encompass dengue virus," exact="West Nile" post="virus, and Zika virus. HCV is an enveloped virus"/>
  <result pre="of viruses that encompass dengue virus, West Nile virus, and" exact="Zika" post="virus. HCV is an enveloped virus with a positive-stranded"/>
  <result pre="of the HCV replication platform. 3. Flavivirus Propagation and Sphingolipids" exact="Dengue" post="virus (DENV), West Nile virus (WNV), and Zika virus"/>
  <result pre="replication platform. 3. Flavivirus Propagation and Sphingolipids Dengue virus (DENV)," exact="West Nile" post="virus (WNV), and Zika virus (ZIKV) are archetype flaviviruses"/>
  <result pre="and Sphingolipids Dengue virus (DENV), West Nile virus (WNV), and" exact="Zika" post="virus (ZIKV) are archetype flaviviruses transmitted by mosquitoes, mainly"/>
  <result pre="aegypti and Aedes albopictus. According to the world health organization," exact="DENV" post="is responsible for 50–100 million infections each year with"/>
  <result pre="flu-like symptoms and major complications, including deadly dengue hemorrhagic fever." exact="WNV" post="causes flu-like symptoms, neuroinvasive disease, and death in many"/>
  <result pre="neuroinvasive disease, and death in many countries in the world." exact="WNV" post="was first introduced in the United States (US) in"/>
  <result pre="for many deaths in birds, humans and horses. By contrast," exact="ZIKV" post="only emerged as a global health concern since 2016,"/>
  <result pre="adults [27,43]. Like hepatitis C virus (HCV), DENV, WNV, and" exact="ZIKV" post="are enveloped viruses. Unlike HCV, the positive-stranded RNA genome"/>
  <result pre="specific antiviral treatments are currently available for DENV, WNV, or" exact="ZIKV" post="infection. 3.1. DENV Propagation and Sphingolipids There is evidence"/>
  <result pre="are currently available for DENV, WNV, or ZIKV infection. 3.1." exact="DENV" post="Propagation and Sphingolipids There is evidence that sphingolipids and"/>
  <result pre="also required for the replication of some flaviviruses. For example," exact="DENV" post="has been reported to upregulate the expression of sphingolipids"/>
  <result pre="study did not directly address the role of sphingolipids in" exact="DENV" post="replication. In a different study, Wang et al. [47]"/>
  <result pre="(GM95) to demonstrate that the glycosphingolipid GM3 is required for" exact="DENV" post="genome replication. The authors found higher levels of GM3"/>
  <result pre="in DENV-infected cells and relocalization of GM3 to sites where" exact="DENV" post="replicates its genome. Importantly, the authors found that inhibition"/>
  <result pre="DENV-infected mice [47]. While the exact role of GM3 in" exact="DENV" post="genome replication is currently unknown, these in vivo findings"/>
  <result pre="can serve as a foundation for new antiviral therapy. 3.2." exact="WNV" post="Propagation and Sphingolipids 3.2.1. Sphingolipids and WNV Entry and"/>
  <result pre="antiviral therapy. 3.2. WNV Propagation and Sphingolipids 3.2.1. Sphingolipids and" exact="WNV" post="Entry and Genome Replication The role of sphingomyelin in"/>
  <result pre="WNV Entry and Genome Replication The role of sphingomyelin in" exact="WNV" post="replication is well documented. A study by Martin-Acebes and"/>
  <result pre="documented. A study by Martin-Acebes and colleagues [48] showed that" exact="WNV" post="replicates at a much higher level in mice deficient"/>
  <result pre="their wild type controls. This suggested that sphingomyelin accumulation enhances" exact="WNV" post="infectivity. Consistent with these findings, adding sphingomyelin to infected"/>
  <result pre="these findings, adding sphingomyelin to infected fibroblast cells markedly increased" exact="WNV" post="infectivity. Further analysis showed that sphingomyelin colocalizes with WNV"/>
  <result pre="increased WNV infectivity. Further analysis showed that sphingomyelin colocalizes with" exact="WNV" post="dsRNA at cytoplasmic foci, implying that sphingomyelin plays a"/>
  <result pre="that sphingomyelin plays a role in the formation of the" exact="WNV" post="replication platform [48]. Interestingly, pharmacological inhibitors of sphingomyelin synthesis"/>
  <result pre="sphingomyelin synthesis (DS609 and SPK-601) markedly reduced the infectivity of" exact="WNV" post="released from infected cells, but had little impact on"/>
  <result pre="[48]. These findings imply that sphingomyelin is also required for" exact="WNV" post="attachment, internalization, and/or virus–endosome fusion. 3.2.2. Sphingolipids and WNV"/>
  <result pre="for WNV attachment, internalization, and/or virus–endosome fusion. 3.2.2. Sphingolipids and" exact="WNV" post="Particle Formation In an earlier report, Martin-Acebes and colleagues"/>
  <result pre="an earlier report, Martin-Acebes and colleagues [49] also showed that" exact="WNV" post="particles were enriched in sphingomyelin. Surprisingly, pharmacological inhibition of"/>
  <result pre="of neutral sphingomyelinase (converts sphingomyelin into ceramide and phosphorylcholine) reduced" exact="WNV" post="release from infected cells, implying perhaps that ceramide generated"/>
  <result pre="ceramide generated from sphingomyelin catabolism is critical for the infectious" exact="WNV" post="particle. Subsequent analysis showed that inhibition of neutral sphingomyelinase"/>
  <result pre="of neutral sphingomyelinase activity reduces the budding of the immature" exact="WNV" post="particles, a crucial step in infectious WNV particle formation"/>
  <result pre="of the immature WNV particles, a crucial step in infectious" exact="WNV" post="particle formation [49]. While this study appears to be"/>
  <result pre="be at odds with the putative role of sphingomyelin in" exact="WNV" post="entry, it also highlights the role of sphingomyelin in"/>
  <result pre="the role of sphingomyelin in two distinct steps of the" exact="WNV" post="replication cycle. 3.3. ZIKV Replication and Sphingolipids The role"/>
  <result pre="in two distinct steps of the WNV replication cycle. 3.3." exact="ZIKV" post="Replication and Sphingolipids The role of sphingolipids and glycosphingolipids"/>
  <result pre="Replication and Sphingolipids The role of sphingolipids and glycosphingolipids in" exact="ZIKV" post="replication is not well understood. This is crucial because"/>
  <result pre="ZIKV replication is not well understood. This is crucial because" exact="ZIKV" post="patients with Guillain–Barré Syndrome, have elevated levels of antibodies"/>
  <result pre="the need to define the role of glucosylceramide-derived glycosphingolipids in" exact="ZIKV" post="infectivity. Our group has evidence that ZIKV particles are"/>
  <result pre="glucosylceramide-derived glycosphingolipids in ZIKV infectivity. Our group has evidence that" exact="ZIKV" post="particles are enriched in sphingomyelin, ceramide, and glucosylecramide (unpublished"/>
  <result pre="glycosphingolipids leading to gangliosides biosynthesis (Figure 1) are required for" exact="ZIKV" post="particle assembly (unpublished data). Current efforts are focused on"/>
  <result pre="efforts are focused on understanding how sphingolipids and glycosphingolipids regulate" exact="ZIKV" post="infectivity. 4. Human Immunodeficiency Virus’s Propagation and Sphingolipids Human"/>
  <result pre="References References 1.NowakowskiT.J.PollenA.A.Di LulloE.Sandoval-EspinosaC.BershteynM.KriegsteinA.R.Expression Analysis Highlights AXL as a Candidate" exact="Zika" post="Virus Entry Receptor in Neural Stem CellsCell Stem Cell20161859159610.1016/j.stem.2016.03.01227038591"/>
  <result pre="Stem Cell20161859159610.1016/j.stem.2016.03.01227038591 2.RichardA.S.ShimB.-S.KwonY.-C.ZhangR.OtsukaY.SchmittK.BerriF.DiamondM.S.ChoeH.AXL-dependent infection of human fetal endothelial cells distinguishes" exact="Zika" post="virus from other pathogenic flavivirusesProc. Natl. Acad. Sci. USA20171142024202910.1073/pnas.162055811428167751"/>
  <result pre="USA20171142024202910.1073/pnas.162055811428167751 3.MeertensL.CarnecX.LecoinM.P.RamdasiR.Guivel-BenhassineF.LewE.LemkeG.SchwartzO.AmaraA.The TIM and TAM families of phosphatidylserine receptors mediate" exact="Dengue" post="virus entryCell Host Microbe20121254455710.1016/j.chom.2012.08.00923084921 4.AligoJ.JiaS.MannaD.KonanK.V Formation and function of"/>
  <result pre="Natl. Acad. Sci. USA1999969142914710.1073/pnas.96.16.914210430909 27.Cao-LormeauV.-M.BlakeA.MonsS.LastèreS.RocheC.VanhomwegenJ.DubT.BaudouinL.TeissierA.LarreP.et al.Guillain-Barré Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 28.HulkovaH.LedvinovaJ.KucharL.SmidF.HonzikovaJ.EllederM.Glycosphingolipid"/>
  <result pre="secretory apparatusJ. Virol.2003777843785510.1128/JVI.77.14.7843-7855.200312829824 43.PaploskiI.A.D.PratesA.P.P.B.CardosoC.W.KikutiM.SilvaM.M.O.WallerL.A.ReisM.G.KitronU.RibeiroG.S.Time lags between exanthematous illness attributed to" exact="Zika" post="virus, Guillain-Barré syndrome, and microcephaly, Salvador, BrazilEmerg. Infect. Dis.2016221438144410.3201/eid2208.16049627144515"/>
  <result pre="Cell20161966367110.1016/j.stem.2016.07.01927524440 46.YuanL.HuangX.-Y.LiuZ.-Y.ZhangF.ZhuX.-L.YuJ.-Y.JiX.XuY.-P.LiG.LiC.et al.A single mutation in the prM protein of" exact="Zika" post="virus contributes to fetal microcephalyScience201735893393610.1126/science.aam712028971967 47.WangK.WangJ.SunT.BianG.PanW.FengT.WangP.LiY.DaiJ.Glycosphingolipid GM3 is indispensable"/>
  <result pre="virus contributes to fetal microcephalyScience201735893393610.1126/science.aam712028971967 47.WangK.WangJ.SunT.BianG.PanW.FengT.WangP.LiY.DaiJ.Glycosphingolipid GM3 is indispensable for" exact="Dengue" post="virus genome replicationInt. J. Biol. Sci.20161287288310.7150/ijbs.1564127313500 48.Martín-AcebesM.A.Gabandé-RodríguezE.García-CabreroA.M.SánchezM.P.LedesmaM.D.SobrinoF.SaizJ.-C.Host sphingomyelin increases"/>
  <result pre="Dengue virus genome replicationInt. J. Biol. Sci.20161287288310.7150/ijbs.1564127313500 48.Martín-AcebesM.A.Gabandé-RodríguezE.García-CabreroA.M.SánchezM.P.LedesmaM.D.SobrinoF.SaizJ.-C.Host sphingomyelin increases" exact="West Nile" post="virus infection in vivoJ. Lipid Res.20165742243210.1194/jlr.M06421226764042 49.Martin-AcebesM.A.Merino-RamosT.BlazquezA.-B.CasasJ.Escribano-RomeroE.SobrinoF.SaizJ.-C.The composition of"/>
  <result pre="Nile virus infection in vivoJ. Lipid Res.20165742243210.1194/jlr.M06421226764042 49.Martin-AcebesM.A.Merino-RamosT.BlazquezA.-B.CasasJ.Escribano-RomeroE.SobrinoF.SaizJ.-C.The composition of" exact="West Nile" post="virus lipid envelope unveils a role of sphingolipid metabolism"/>
 </snippets>
</snippetsTree>
